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Abstract
 
The overall size and composition of the pool of naive and memory T cells are tightly regulated
by homeostatic mechanisms. Recent work has shown that homeostasis of naive T cells is con-
trolled by two factors, self-major histocompatibility complex (MHC)/peptide ligands and a cy-
tokine, interleukin (IL)-7. In particular, contact with these two factors is required for naive
CD4
 
 
 
 and CD8
 
 
 
 cells to undergo “homeostatic” proliferation, i.e., proliferation induced as a
consequence of severe T cell depletion. In contrast to naive T cells, the factors that drive mem-
ory T cells to undergo homeostatic proliferation are poorly understood. To address this issue,
purified memory phenotype CD4
 
 
 
 and CD8
 
 
 
 cells from normal mice were adoptively trans-
ferred into various gene-knockout mice rendered T cell–deficient by sublethal irradiation.
Three findings are reported. First, unlike naive T cells, homeostatic proliferation of memory T
cells is largely MHC independent. Second, memory CD8
 
 
 
 cells can utilize either IL-7 or IL-15
to undergo homeostatic proliferation; however, in the absence of both IL-7 and IL-15, ho-
meostatic proliferation fails to occur. Third, unlike memory CD8
 
 
 
 cells, homeostatic prolifera-
tion of memory CD4
 
 
 
 cells is independent of IL-7 and IL-15 (also IL-4). Thus, the homeo-
static proliferation mechanisms that control memory CD8
 
 
 
 cells and memory CD4
 
 
 
 cells are
quite distinct.
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Introduction
 
The total number of T lymphocytes in the body is tightly
controlled by homeostatic mechanisms to remain at a con-
stant level (1–4). Such regulation is manifested by the find-
ing that T cells undergo “homeostatic” proliferation upon
adoptive transfer into T cell–depleted syngenic hosts (1–4).
Recently, it has been shown that naive T cells require
contact with two ligands in order to undergo homeostatic
proliferation in T cell–depleted hosts, namely (i) self-
MHC/peptide complexes and (ii) the cytokine IL-7, a
member of the cytokine family that binds to receptors
 
which share a common 
 
 
 
 (
 
 
 
c
 
)
 
*
 
 chain (5–10). Continuous
contact with self-MHC/peptide and IL-7 is also required
for long-term survival of naive T cells in their normal qui-
escent state (9–19).
Like naive T cells, memory T cells undergo homeostatic
proliferation in lymphopenic hosts (14). However, the fac-
tors controlling homeostatic proliferation of memory T cells
are largely unknown. For CD8
 
 
 
 cells, homeostatic prolifer-
 
ation and survival of these cells is normal in MHC class
I–deficient hosts (14, 20), implying that contact with MHC
ligands is not required. Whether CD4
 
 
 
 memory cells re-
quire MHC contact is less clear. CD4
 
 
 
 memory cells sur-
vive well in MHC class II
 
 
 
 hosts (21), but whether this also
applies to homeostatic proliferation has not been studied.
In addition to proliferating in response to T cell deple-
tion, memory T cells undergo intermittent cell division un-
der normal T cell–sufficient conditions (22–24). Such
background turnover presumably reflects the fact that
memory T cells are more metabolically active than naive T
cells, which rarely divide under normal conditions (22, 25).
The periodic turnover of memory T cells is MHC inde-
pendent, at least for CD8
 
 
 
 cells (14), and occurs without
any significant change in the total size of the memory T
cell pool, implying that background proliferation is offset
by cell death.
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IL-15 and IL-7 Regulation of Memory CD8
 
 
 
 Cell Homeostasis
 
For memory CD8
 
 
 
 cells, recent work has shown that
both survival and background turnover are controlled by
IL-15, another member of the 
 
 
 
c
 
 cytokine family (26–29).
The notion that memory CD8
 
 
 
 cells are controlled by IL-
15 stemmed from the observation that memory phenotype
CD44
 
hi
 
 CD8
 
 
 
 cells selectively express elevated level of
CD122, a shared component of the receptors for IL-2 and
IL-15, and that IL-15 caused selective proliferation of puri-
fied CD44
 
hi
 
 CD8
 
 
 
 cells (26). Direct support for this idea
came from the finding that background turnover of CD44
 
hi
 
CD8
 
 
 
 cells is inhibited with injection of anti-CD122 mAb
though not by anti–IL-2 mAb (28), and that total numbers
of CD122
 
hi
 
 CD44
 
hi
 
 CD8
 
 
 
 cells are selectively reduced in
mice deficient in IL-15 or IL-15R
 
 
 
 chain (27, 29). In con-
trast to memory CD8
 
 
 
 cells, IL-15 appears not to have a
role in homeostasis of memory CD4
 
 
 
 cells (26, 29). This
could be a reflection of low CD122 expression on memory
CD4
 
 
 
 cells (26), but it could also be due to a fundamental
difference in the mechanisms regulating the two popula-
tions of memory cells. In support of this idea, long-lived
memory CD4
 
 
 
 cells, despite expression of the 
 
 
 
c
 
 chain,
can be generated from 
 
 
 
c
 
  
 
CD4
 
 
 
 cells (30, 31), implying
that 
 
 
 
c
 
 family of cytokines (IL-2, -4, -7, -9, -15) are dis-
pensable for survival of memory CD4
 
 
 
 cells.
In this paper, we examined the requirements for MHC
and 
 
 
 
c
 
 cytokines for homeostatic proliferation of memory
CD4
 
 
 
 and CD8
 
 
 
 cells in syngenic T cell–depleted hosts.
As expected from findings on cell survival, memory T cells
do not require contact with MHC molecules for homeo-
static proliferation. In terms of cytokine requirements,
however, the results were unexpected. Thus, based on the
results of transferring T cells to cytokine knockout mice,
memory CD8
 
 
 
 cells were found to utilize either IL-7 or
IL-15 for undergoing efficient homeostatic proliferation in
T cell–depleted hosts. Significantly, complete ablation of
proliferation of memory CD8
 
 
 
 cells occurred in hosts
lacking both IL-7 and IL-15. In contrast to memory CD8
 
 
 
cells, there was little or no evidence that IL-4, IL-7, and
IL-15 controlled homeostatic proliferation of memory
CD4
 
 
 
 cells. In addition, competition experiments involv-
ing coinjection of large numbers of purified naive or
memory T cell populations suggest that homeostatic pro-
liferation of naive CD4
 
 
 
/CD8
 
 
 
 and memory CD8
 
 
 
 cells
are regulated by some overlapping components. Homeo-
static proliferation of memory CD4
 
 
 
 cells, on the other
hand, appears to be regulated independently of other sub-
sets of T cells.
 
Materials and Methods
 
Mice and Antibodies.
 
C57BL/6 (B6), B6.PL, and B6.Ly 5.1
congenic mice were purchased from the breeding colony at The
Scripps Research Institute (TSRI). B6.IL-4
 
–
 
 (32) and B6.
 
 
 
2m
 
 
 
(33) mice were purchased from The Jackson Laboratory. B6.Ly
5.1
 
 
 
 
 
 
 
2m
 
  
 
mice were purchased from Taconic. B6.A
 
 
 
  
 
mice
(34) were provided by T. Laufer (University of Pennsylvania, Phila-
delphia, PA). IL-7
 
  
 
(35), B6.IL-15
 
  
 
(29), B6.IL-7 transgenic (36)
mice were gifts from DNAX, Immunex Corp., and R. Ceredig
(INSERM), respectively; 
 
 
 
2m
 
 
 
K
 
 
 
D
 
  
 
mice (14, 37), generated
by F. Lemonnier (Institut Pasteur, Paris, France), were provided
by R. Ahmed (Emory University, Atlanta, GA). 
 
 
 
2m
 
 
 
A
 
 
 
  
 
and
IL-7
 
 
 
 IL-15
 
 
 
 double deficient mice were bred at The Scripps
Research Institute. Hybridomas secreting anti–IL-7R
 
 
 
 (A7R34)
mAb (38) and anti–IL-7 (M25) mAb (39) (generated by Immu-
nex Corp.) were provided by P. Marrack (National Jewish Medi-
cal and Research Center, Denver, CO).
 
Adoptive Transfer of T Cells.
 
Naive (CD44
 
lo
 
) and memory
(CD44
 
hi
 
) CD4
 
 
 
 and CD8
 
 
 
 cells were obtained as follows.
Pooled LN and spleen cells from adult mice at 6–12 mo of age
were first depleted of non-T cells by treating with a cocktail of
anti-HSA (clone J11D) and anti-A
 
b
 
 (clone 28–16–8S) mAbs plus
complement. Cells were then stained with FITC-conjugated
anti-CD4 (clone RM4–5; eBioscience), PE-conjugated anti-
CD44 (eBioscience), and Cy5-conjugated anti-CD8 (eBio-
science), and then sorted for CD44
 
lo
 
 or CD44
 
hi
 
 CD4
 
 
 
 and CD8
 
 
 
cells using Becton Dickinson Vantage™ SE. Sorted cells were la-
beled with CFSE (Molecular Probes) as described previously (7,
40). Aliquots of 1–2 
 
 
 
 10
 
6
 
 cells were injected intravenously into
mice exposed to 600 cGy whole body irradiation 1 d before cell
transfer. After 7 or 8 d, host LN and spleen cells were stained
with the appropriate mAbs and analyzed by flow cytometry (7).
High numbers of naive and memory phenotype bystander T
cells were obtained as follows. LN cells from young B6 mice (for
naive T cells) or from IL-7 transgenic mice (for memory CD8
 
 
 
cells) were depleted of non-T cells as described above and panned
for T cells using plates coated with both anti-CD4 (clone RL172)
and anti-CD8 (clone 3.168) mAbs (7). Purified T cells were
stained with biotinylated anti-CD44 (eBioscience) mAb followed
by FITC-conjugated streptavidin (Jackson ImmunoResearch
Laboratories), followed by biotinylated magnetic microbeads
(Miltenyi Biotec). These cells were then passed through MACS
 
®
 
LS separation columns (Miltenyi Biotec) to either collect CD44
 
lo
 
eluent cells or bound CD44
 
hi
 
 cells. All FACS
 
®
 
 and column-puri-
fied cells were 
 
 
 
98% pure.
 
FACS
 
®
 
 Analysis.
 
LN or spleen cells were stained for donor
cells as described previously (7). Thy-1.1
 
 
 
 donor cells were de-
tected by staining with biotinylated OX-7 (BD PharMingen) fol-
lowed by Cy5-conjugated streptavidin (Jackson ImmunoRe-
search Laboratories) plus PE-conjugated anti-CD4 (eBioscience).
Ly 5.1
 
 
 
 donor cells were detected by staining with Cy5-conju-
gated A20–1.7 (41) plus PE-conjugated anti-CD4 (eBioscience).
Simultaneous detection of both Thy-1.1
 
 
 
 and Ly 5.1
 
 
 
 cells was
achieved by staining with biotinylated OX-7 followed by PE-
conjugated streptavidin (Jackson ImmunoResearch Laboratories)
plus Cy5-conjugated A20–1.7 and PE-Cy5–conjugated anti-
CD4 (eBioscience). To determine expression of cytokine recep-
tors on T cells, LN cells from B6.PL mice were stained with ei-
ther PE-conjugated anti–IL-2R
 
 
 
 (BD PharMingen), biotinylated
anti–IL-7R
 
 
 
 (clone A7R34) followed by PE-conjugated strepta-
vidin, or anti-
 
 
 
c
 
 (clone 4G3; BD PharMingen) followed by bio-
tinylated anti–rat IgG (Jackson ImmunoResearch Laboratories)
followed by PE-conjugated streptavidin; the cells were then
stained with FITC-labeled anti-CD44 and either Cy5-labeled
anti-CD4 or anti-CD8 (eBioscience). PE- or unconjugated rat
IgG Ab (Jackson ImmunoResearch Laboratories) was used for
background staining.
 
Generation of Bone Marrow Chimeras.
 
A mixture of 3.5 
 
  
 
10
 
6
 
B6.Ly 5.1
 
 
 
 
 
 
 
2m
 
  
 
and 1.5 
 
  
 
10
 
6
 
 B6 bone marrow (BM) cells
were injected into lethally irradiated (1,000 cGy) B6 mice that also
received 100 
 
 
 
l of PK136 (anti-NK1.1) (42) ascites 1 d before.
 
 
 
2m
 
–
 
 T cells were obtained from these chimeras 3–6 mo later. 
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Results
 
Unless stated otherwise, the memory T cells used in this
study were obtained by sorting for polyclonal CD44
 
hi
 
CD4
 
 
 
 and CD44hi CD8  cells prepared from normal
B6.PL (Thy-1.1 ) mice at 6–12 mo of age; sorted poly-
clonal B6.PL or B6.Ly 5.1  CD44lo cells were used as a
source of naive T cells. Proliferation of CFSE-labeled do-
nor T cells injected intravenously into irradiated B6 (Thy-
1.2  Ly 5.2 ) hosts was analyzed 7–8 d later by double-
staining for Thy-1.1 and/or Ly 5.1 and CD4 to identify
donor CD4  and CD8  (CD4 ) cells. In some experi-
ments a mixture of CFSE-labeled B6.PL CD44hi CD4 /
CD8  and B6.Ly 5.1  CD44lo CD4 /CD8  cells were in-
jected and triple stained for Thy-1.1, Ly 5.1, and CD4 to
identify all four populations of donor cells. All hosts were T
cell–depleted by exposure to a light dose of whole body ir-
radiation (600 cGy) 1 d before donor cell injection.
The results discussed below refer to T cell proliferation,
as measured by CFSE dilution. With regard to cell recover-
ies, total numbers of donor cells recovered from spleen and
pooled LN of hosts injected with CD44lo cells were gener-
ally in the order of 20–40% of the injected cell numbers if
the cells proliferated strongly and 5–10% if the cells re-
mained largely in interphase; recoveries from recipients of
CD44hi cells were about twofold lower. Recoveries of
CD8  cells were usually twofold higher than CD4  cells.
For cells transferred to IL-7  hosts, cell recoveries were
more variable than for other gene-knockout hosts and may
have reflected that the IL-7  hosts were backcrossed only
twice to a B6 background.
Proliferation of Memory T Cells in T Cell–depleted Syngenic
Hosts. As shown previously for naive T cells (7), sorted
CD44lo CD4  and CD8  cells underwent slow homeo-
static proliferation during the 8-d period after injection
into syngenic T cell–depleted B6 hosts (Fig. 1 A). Homeo-
static proliferation was also evident for sorted memory phe-
notype CD44hi CD4  and CD8  cells during this period,
but with faster kinetics of proliferation than for naive T
cells (Fig. 1 A). Interestingly, proliferation of CD44hi
CD4  cells yielded two distinct populations, a fast-dividing
subset that became CFSE  and a population of cells that ei-
ther did not divide or underwent only 1–3 rounds of cell
division. Homeostatic proliferation of memory CD8  cells,
on the other hand, was more homogeneous, as reported
previously (14). Thus, CD44hi CD8  cells uniformly un-
derwent 2–6 rounds of cell division (Fig. 1 A); very few
cells divided extensively, i.e., became CFSE . In general,
CD44hi CD8  cells underwent 2–3 more rounds of cell
division than CD44lo CD8  cells.
Role of MHC in Homeostatic Proliferation. As reported
previously (5–8), homeostatic proliferation of naive CD44lo
CD4  and CD8  cells was minimal in irradiated hosts
lacking MHC class II (B6.A  ) and MHC class I
( 2m K D ) molecules, respectively (Fig. 1 A). In
marked contrast to naive T cells, homeostatic proliferation
of memory CD44hi T cells did not require contact with
MHC molecules. Thus, proliferation of CD44hi CD4 
cells was as prominent in MHC class II  hosts as in normal
B6 hosts (Fig. 1 A). Likewise, confirming previous findings
(14), CD44hi CD8  cells proliferated extensively in both
MHC class I  and normal hosts.
Figure 1. Homeostatic proliferation of naive and memory T cells in T
cell–depleted syngenic hosts. (A) LN and spleen cells from B6.PL mice
were sorted for naive (CD44lo) or memory phenotype (CD44hi) CD4  and
CD8  T cells. Small numbers (106 cells per mouse) of CFSE-labeled
CD44lo or CD44hi cells were intravenously injected into irradiated (600
cGy) B6, B6. H2-A  , and  2m K D  mice; proliferation of donor cells
was analyzed 7 d later by flow cytometry after staining host LN and spleen
cells for Thy-1.1 and CD4. Shown are CD44 profiles on the sorted donor
cells before injection (left column), and the CFSE profiles on gated donor
CD4  (Thy-1.1  CD4 ) and CD8  (Thy-1.1  CD4 ) cells in the LN in
the indicated hosts (right columns). Similar results were found in the spleen.
(B) Small numbers (106 cells per mouse) of sorted CFSE-labeled CD44lo or
CD44hi T cells were injected into two groups of irradiated (600 cGy) B6,
B6. 2m , B6.A  , and B6. 2m  A   mice; proliferation of donor cells
was analyzed 7 d later. The injected donor cells were deficient in MHC
class I molecules to prevent rejection by B6. 2m A   mice. MHC class
I–deficient donor cells were obtained from mixed BM chimeras generated
by reconstituting lethally irradiated B6 mice with a mixture of  2m-deficient
B6.Ly 5.1  and normal B6 BM cells as described in Materials and Methods.
Shown are representative CFSE profiles on gated donor CD44lo or CD44hi
CD4  (Ly5.1  CD4 ) cells in the host LN. All host mice were pretreated
with anti-NK1.1 (clone PK136) mAb to prevent rejection of  2m  donor
cells. Similar results were obtained from two other experiments.1526 IL-15 and IL-7 Regulation of Memory CD8  Cell Homeostasis
For CD44hi CD4  cells, the strong homeostatic prolifer-
ation of these cells in irradiated MHC class II  hosts also
applied in combined MHC class I II  (B6. 2m A  )
hosts (Fig. 1 B). Likewise, CD44hi CD8  cells proliferated
well in both MHC class I  and MHC class I  II  hosts
(data not shown). Thus, for memory CD44hi T cells, ho-
meostatic proliferation was independent of both MHC
class I and MHC class II molecules. Note that, because of
unexplained rejection of T cells in combined MHC I II 
hosts, the T cells used in Fig. 1 B were raised in BM chi-
meras (see Materials and Methods).
Role of  c Cytokines in Homeostatic Proliferation of Memory T
Cells. To assess the role of  c cytokines, we examined
homeostatic proliferation in IL-4 , IL-7 , and IL-15 
hosts. Confirming previous findings (9, 10), homeostatic
proliferation of naive CD44lo CD4  and CD8  cells was
largely ablated in IL-7  hosts but retained in IL-4  and IL-
15  hosts (Fig. 2). Homeostatic proliferation of naive T
cells was thus strongly dependent on IL-7 but relatively in-
dependent of IL-4 and IL-15. The results for memory T
cells were somewhat different.
For CD44hi CD4  cells, proliferation of these cells in IL-
4 , IL-7 , and IL-15  hosts was almost as marked as in
normal B6 hosts. This finding, which was seen in several
other experiments (Figs. 3 B and 4), indicated that IL-4,
IL-7, and IL-15 played little if any role in homeostatic pro-
liferation of CD44hi CD4  cells.
As for CD44hi CD4  cells, homeostatic proliferation of
CD44hi CD8  cells occurred in all three knockout hosts
(Fig. 2). However, the extent of proliferation in these
hosts was variable. In some experiments (3 out of 6), pro-
liferation of CD44hi CD8  cells was considerably reduced
in IL-7  hosts (Fig. 3 B) but this was not an invariable
finding (Figs. 2 and 4). Likewise, proliferation in IL-15 
hosts was reduced in some experiments (2 out of 6; Fig. 4),
but not in others (Fig. 2 and 3 B). Proliferation in IL-4 
hosts, however, was not reduced (Fig. 2 and data not
shown).
Roles for Both IL-7 and IL-15 in Homeostatic Proliferation of
Memory CD8  Cells. The above results suggest that ho-
meostatic proliferation of CD44hi CD8  cells is relatively
independent of IL-4, IL-7, and IL-15. However, an alter-
native possibility is that proliferation is controlled by multi-
ple cytokines rather than by a single cytokine. Here, we
considered the idea that proliferation could be controlled
by both IL-7 and IL-15, the presence of IL-15 in IL-7 
hosts compensating for the lack of IL-7, and vice versa in
IL-15  hosts. This idea seemed plausible because (i) IL-7
clearly played a decisive role for homeostatic proliferation
of naive T cells and (ii) IL-15 is known to control the
background proliferation of CD44hi CD8  cells in nonirra-
diated hosts (Introduction). In addition, CD44hi CD8 
cells show high expression of receptors for both IL-7 and
IL-15. Thus, as shown in Fig. 3 A, expression of IL-7R ,
and also  c, was as prominent on CD44hi CD8  cells as on
other T cells. Likewise, expression of CD122, an important
component of the receptor for IL-15 (and IL-2), was
prominent on CD44hi CD8  cells, in fact far higher on
these cells than on other T cell subsets (reference 26 and
Fig. 3 A).
If either IL-7 or IL-15 can control homeostatic prolifera-
tion of CD44hi CD8  cells, depletion of both cytokines
would be expected to prevent proliferation. To test this
prediction, T cells were transferred to irradiated IL-15 
hosts; responsiveness to IL-7 in these hosts was then
blocked by injecting the mice with a mixture of anti–IL-7
(M25) and anti–IL-7R  (A7R34) mAbs. As shown in Fig.
3 B, this treatment totally inhibited proliferation of naive
CD44lo CD4  and CD8  T cells, thus indicating that mAb
treatment was effective in blocking responsiveness to IL-7.
Significantly, the same finding applied to CD44hi CD8 
cells. Thus, proliferation of these cells was near normal in
control Ab-treated IL-15  hosts (relative to B6 hosts) but
markedly reduced in IL-15  hosts given anti–IL-7/7R 
mAbs. The latter treatment had little or no effect on prolif-
eration of CD44hi CD4  cells.
Figure 2. Homeostatic prolif-
eration of naive and memory
phenotype T cells in cytokine-
deficient mice. Small numbers
(106 cells per mouse) of CFSE-
labeled sorted B6.Ly 5.1 CD44lo,
and CD44hi T cells were injected
into groups of irradiated (600
cGy) B6, B6.IL-4 , IL-7 , and
B6.IL-15  mice and analyzed 7 d
later for proliferation of donor
cells in host lymphoid tissues.
Shown are CFSE profiles of
gated donor CD44lo or CD44hi
CD4  (Ly5.1  CD4 ) and
CD8  (Ly5.1  CD4 ) cells in
host LN 7 d after transfer. Data
are representative of two separate
experiments using a total of four
mice for each host type.1527 Tan et al.
The above data thus provided strong support for the no-
tion that homeostatic proliferation of CD44hi CD8  cells
(but not CD44hi CD4  cells) is under the joint control of
two cytokines, IL-7 and IL-15. Further support for this
idea came from the finding that homeostatic proliferation
of CD44hi CD8  cells was virtually abolished in combined
IL-7  IL-15  hosts (Fig. 4). Proliferation of CD44hi CD4 
cells in these hosts, by contrast, was unimpaired.
Competition between Naive and Memory T Cells for Cyto-
kines. In previous studies, it was found that homeostatic
proliferation of naive T cells could be markedly inhibited by
coinjecting large numbers of unlabeled “bystander” T cells
(7, 43). The mechanism of inhibition was not established,
though competition for MHC–peptide ligands was ex-
cluded. In light of the above results, the inhibition of naive
T cells could reflect competition for cytokines, notably,
IL-7. If so, comparable inhibition might apply to memory
CD44hi CD8  cells, but only if the competing cells removed
both IL-7 and IL-15. In the experiments discussed below,
we tested this idea by examining whether bulk populations
of T cells could inhibit proliferation of memory CD44hi
CD8  cells; inhibition of naive T cells was used as a control.
For naive T cells, our previous data showing inhibition
of proliferation by bulk populations of T cells referred to
unseparated T cells, i.e., a mixture of naive and memory
cells. As shown in Fig. 5 A, proliferation of CFSE-labeled
CD44lo CD8  cells in either B6 hosts (group 1) or IL-15 
hosts (group 2) was strongly inhibited by coinjection of a
large dose (3–4   107) of purified CD44lo T cells. Since
proliferation of CD44lo T cells is selectively dependent on
IL-7 (see above), bulk populations of CD44lo T cells, being
IL-7Rhi, presumably inhibit proliferation by binding and
removing IL-7, thus depriving the coinjected naive CFSE-
labeled T cells from contact with IL-7.
Despite being able to absorb IL-7, bulk populations of
CD44lo T cells, being CD122lo, would presumably have
only limited capacity to remove IL-15. Hence, one would
not expect these cells to inhibit proliferation of memory
CD44hi CD8  cells, i.e., cells that can utilize either IL-7 or
IL-15 for proliferation. In agreement with this prediction,
despite strongly inhibiting proliferation of naive T cells,
bulk populations of unlabeled CD44lo T cells failed to in-
hibit proliferation of CFSE-labeled memory CD44hi CD8 
cells in irradiated B6 mice (group 1). Here, proliferation of
CD44hi CD8  cells was presumably driven by IL-15, IL-7
having been removed by absorption. If so, quite different
results would be expected in IL-15  hosts, i.e., a situation
where, according to the above results (Figs. 3 and 4), pro-
Figure 3. Role of IL-7 and
IL-15 for homeostatic prolifera-
tion of naive and memory phe-
notype T cells. (A) Expression of
IL-2R  (CD122), IL-7R 
(CD127), and  c (CD132) on
CD44lo or CD44hi T cells. LN
cells from a young B6.PL mouse
were stained for the indicated
cytokine receptors and also for
CD44, CD4, and CD8. Shown
are expression levels of the indi-
cated cytokine receptors (black)
and background control (white)
on gated CD44lo, CD44hi
CD4 , and CD8  cells. (B)
Blocking IL-7 in IL-15   mice
suppresses homeostatic prolifera-
tion of CD44hi CD8  cells. A
mixture of CFSE-labeled sorted
B6.Ly 5.1  CD44lo T cells (106
cells per mouse) and B6.PL
CD44hi T cells (106 cells per
mouse) were injected into irradi-
ated (600 cGy) B6, IL-7 , and
IL-15  mice. Host mice were ei-
ther treated with a mixture of
control mouse and rat IgG or
with a cocktail of anti–IL-7R 
(clone A7R34) and anti–IL-7
(clone M25) mAbs. Cocktails
containing 500 ug of each anti-
body were intraperitoneally in-
jected every other day for a total
of four times starting 1 d before
cell transfer. Shown are CFSE
profiles of donor CD44loCD4  (Ly 5.1  CD4 ), CD44lo CD8  (Ly5.1  CD4–), CD44hi CD4  (Thy1.1  CD4 ), or CD44hi CD8  (Thy1.1  CD4 )
cells in the host LN 7 d after transfer. One other experiment showed similar results.1528 IL-15 and IL-7 Regulation of Memory CD8  Cell Homeostasis
liferation is driven solely by IL-7. Here, we predicted that
IL-15  hosts given bulk populations of CD44lo T cells
would lack IL-7 as well as IL-15 and would thus fail to al-
low proliferation of CFSE-labeled CD44hi CD8  cells.
Surprisingly, this was not the case; in fact, despite minimal
proliferation of CFSE-labeled CD44lo T cells, proliferation
of CD44hi CD8  cells in IL-15  hosts given bulk popula-
tions of CD44lo T cells was almost as high as in control B6
mice (group 2).
One explanation for this unexpected finding is that, after
injection of bulk populations of naive CD44lo T cells, these
cells localized in the T cell–dependent areas of the lym-
phoid tissues and thus caused local absorption of IL-7 in
these sites but not in other sites. Since proliferation of naive
T cells is largely restricted to the T cell–dependent areas,
one can envisage that local absorption of IL-7 in these areas
is sufficient to block proliferation of naive T cells. How-
ever, the situation for CD44hi CD8  cells could be differ-
ent. Thus, because of less stringent requirements for con-
tact with professional APC (14), homeostatic proliferation
of CD44hi CD8  cells might be able to occur outside the T
cell–dependent areas. If so, local absorption of IL-7 only in
the T cell–dependent areas would not block proliferation
of CD44hi CD8  cells.
To assess this model, we examined whether proliferation
of CD44hi CD8  cells could be blocked by coinjecting
bulk populations of CD44hi CD8  cells, i.e., cells that pre-
sumably localize in the same sites as the proliferating cells.
Since purifying large numbers of CD44hi CD8  cells from
normal mice was impractical, we used IL-7 transgenic mice
Figure 4. Mice deficient in both IL-7 and IL-15 fail to support ho-
meostatic proliferation of memory phenotype CD8  cells but support effi-
cient homeostatic proliferation of memory phenotype CD4  cells. Small
numbers (106) of sorted and CFSE-labeled B6.PL CD44hi T cells were
transferred into irradiated B6, IL-7 , IL-15 , and combined IL-7  IL-15 
mice; proliferation of donor cells was examined 7 d later. Shown are
CFSE profiles of gated donor CD44hi CD4  and CD44hi CD8  cells in
the LN. Similar results were obtained from two other experiments.
Figure 5. Competition between naive and memory phenotype T cells
for factors driving homeostatic proliferation. (A) Coinjection of large
numbers of CD44lo T cells fails to inhibit homeostatic proliferation of
CD44hi CD8  cells, but coinjection of large numbers of CD44hi CD8 
cells blocks homeostatic proliferation of CD44lo T cells. A mixture of
CFSE-labeled sorted B6.Ly 5.1  CD44lo T cells (106 cells per mouse) and
B6.PL CD44hi T cells (106 cells per mouse) was injected into a group of
irradiated (600 cGy) B6 or B6.IL-15  mice. Half of the hosts were then
injected with a large number (3–4   107) of magnetic bead-purified B6
CD44lo T cells or CD44hi CD8  cells obtained as described in Materials
and Methods. CD44hi CD8  cells were obtained from B6.IL-7 transgenic
mice. Donor cells in the host LN and spleen were examined 7 d later.
Shown are CFSE profiles on gated donor CD44lo and CD44hi CD8  cells.
Note that each group represents separate experiments; hence, representa-
tive control proliferations of CFSE-labeled donor cells in the absence of
coinjected bystander cells is shown for each group. Results are representa-
tive of two to three independent experiments. (B) Failure of bystander na-
ive T cells or CD44hi CD8  cells to diminish proliferation of CD44hi
CD4  cells. Representative data on gated donor CD44lo and CD44hi
CD4  cells from some of the experiments described in A are shown.1529 Tan et al.
(36) as donors. Numbers of CD44hi CD8  cells in these
mice are greatly expanded, presumably through contact
with high levels of IL-7 (44). However, by all parameters
tested, these cells (which do not themselves synthesize IL-7)
are identical to normal T cells, both in terms of phenotype
and requirements for homeostatic proliferation (44). As
shown in Fig. 5 A, coinjecting large numbers of CD44hi
CD8  cells into IL-15  hosts did indeed markedly inhibit
proliferation of CFSE-labeled CD44hi CD8  cells (group
4). Interestingly, substantial inhibition of proliferation of
CD44hi CD8  cells also occurred in B6 hosts (group 3).
Here, being CD122hi as well as IL-7Rhi, the bulk popula-
tion of CD44hi CD8  cells presumably inhibited prolifera-
tion by depleting both IL-7 and IL-15.
The above data thus indicate that, unlike CD44lo cells,
bulk populations of CD44hi CD8  cells caused strong inhi-
bition of proliferation of CD44hi CD8  cells, presumably
because both the competing and responding cells localize
in the same tissue sites. Under these conditions, the com-
peting cells cause local removal of both IL-7 and IL-15 (or
just IL-7 in IL-15– hosts) and thus deprive the proliferating
T cells from contact with these two cytokines. In control
experiments, bulk populations of CD44hi CD8  cells failed
to impair proliferation of CD44hi CD4  cells (Fig. 5 B).
This finding was expected because, as discussed earlier (Fig.
4), proliferation of CD44hi CD4  cells appears to be IL-7
and IL-15 independent.
Discussion
In previous studies, it was shown that homeostatic pro-
liferation of naive T cells is driven by self-MHC ligands
and requires contact with IL-7 (5–10). Memory pheno-
type T cells also undergo homeostatic proliferation (14)
but the requirements for stimulating these cells are largely
unknown. For CD8  cells, the prior observation that ho-
meostatic proliferation of CD44hi CD8  cells occurred in
MHC class I  hosts raised the question whether prolifera-
tion of memory phenotype T cells is driven by cytokines.
As shown here, homeostatic proliferation of memory phe-
notype CD8  cells is indeed cytokine dependent and is
controlled by two different  c cytokines, IL-7 and IL-15.
By contrast,  c cytokines do not appear to be involved in
proliferation of memory phenotype CD4  cells. Before
discussing memory phenotype T cells, it is important to
consider the role of cytokines in controlling proliferation
of naive T cells.
For naive phenotype CD44lo T cells, our results confirm
that TCR contact with self-MHC/peptide ligands and ex-
posure to IL-7 are both essential for homeostatic prolifera-
tion of these cells (5–10). Thus, homeostatic proliferation
of purified polyclonal CD44lo T cells was very limited in
MHC  hosts and IL-7  hosts but unimpaired in IL-4  and
IL-15  hosts. Confirming previous findings with unsepa-
rated T cells (5–10), coinjection of bulk populations of pu-
rified CD44lo T cells or CD44hi CD8  cells greatly reduced
homeostatic proliferation of naive T cells. The simplest ex-
planation for this finding is that, by homing to the T cell–
dependent areas of the lymphoid tissues, the coinjected T
cells caused local depletion of IL-7: naive T cells making
contact with self-MHC ligands on dendritic cells in the T
cell–dependent areas were starved of IL-7 and failed to pro-
liferate. Here, it is notable that, unlike T cells, bulk popula-
tions of B cells fail to inhibit homeostatic proliferation of
naive T cells (7). This finding may reflect that, although IL-
7R expression on B cells is high, B cells fail to localize in
the T cell–dependent areas and for this reason fail to de-
plete IL-7 in these areas.
For memory phenotype T cells, prior evidence that ho-
meostatic proliferation of these cells is MHC independent
was limited to the finding that proliferation of CD44hi
CD8  cells was able to occur in MHC class I  hosts (14).
In extending this finding, we show here that homeostatic
proliferation is MHC independent for both CD4  and
CD8  memory phenotype cells. Moreover, these cells un-
dergo efficient homeostatic proliferation in the combined
absence of both class I and II MHC molecules, indicating
that even suboptimal signaling through TCR recognition
of the “opposite” class of MHC molecules (e.g., class I for
CD4  cells) is not required for homeostatic proliferation.
Recent work has shown that, under normal T cell–suffi-
cient conditions, homeostasis of CD8  memory phenotype
T cells is controlled by IL-15 (26–29). The dependency of
CD44hi CD8  cells on IL-15 applies both to cell survival
and turnover and is restricted to a subset of cells ( 70% of
CD44hi CD8  cells) expressing a high density of CD122
(IL-2R ) (unpublished data), an important component of
the receptor for both IL-15 and IL-2 (45). IL-15  (29) and
IL-15R   (27) mice show reduced numbers of CD44hi
CD8  cells and, at least for IL-15  mice, are virtually
devoid of CD122hi cells (unpublished data). Likewise,
CD122hi CD8  cells from normal mice disappear rapidly
and fail to divide after transfer to IL-15  hosts (unpublished
data). In light of these findings, we expected that homeo-
static proliferation of memory CD8  cells would be very
limited in T cell–depleted IL-15  hosts. Surprisingly, how-
ever, homeostatic proliferation of CD44hi CD8  cells was
clearly apparent in irradiated IL-15  hosts, and also in IL-4 
and IL-7  hosts. The key finding was that homeostatic pro-
liferation of CD44hi CD8  cells was abolished in combined
IL-15  IL-7  hosts. Therefore, the implication is that, un-
der T cell–depleted conditions, IL-7 and IL-15 are func-
tionally interchangeable and either of these cytokines is able
to induce homeostatic proliferation of CD44hi CD8  cells.
This contrasts sharply with the situation in normal T cell–
sufficient mice where only IL-15 appears to be important.
Although CD44hi CD8  cells are highly sensitive to IL-
15 (26–29), the observation that IL-7 can drive homeo-
static proliferation of these cells is rather unexpected be-
cause there is very little precedent for the notion that IL-7
has a role in memory CD8  cell homeostasis. Nevertheless,
it was recently reported that CD8  OT-I TCR transgenic
cells deficient in expression of IL-7R  were much less effi-
cient than wild-type OT-I cells in generating memory
CD8  cells upon adoptive transfer into normal B6 hosts,
despite a similar level of expansion during the primary re-1530 IL-15 and IL-7 Regulation of Memory CD8  Cell Homeostasis
sponse to antigen (9). However, because IL-7 is crucial for
thymopoiesis, the few T cells that are generated in IL-
7R   mice may be abnormal in their ability to convert to
memory cells and/or respond to IL-15. Furthermore, if
IL-7 was able to compensate for the absence of IL-15 un-
der normal T cell–sufficient conditions, one would expect
both IL-15  and IL-15R  mice to possess normal numbers
of CD44hi CD8  cells, which is not the case.
If IL-7 is not required for maintaining CD44hi CD8 
cells in normal mice, why is IL-7 important for controlling
homeostatic proliferation of CD44hi CD8  cells in T cell–
depleted hosts? Different levels of IL-7 in these two situa-
tions could be a key factor. Thus, in normal mice, local ab-
sorption of IL-7 by the large numbers of T cells residing in
the T cell areas may keep IL-7 at a low level. In T cell–
depleted mice, by contrast, reduced absorption of IL-7 by
T cells may cause the local concentration of IL-7 to rise to
a level sufficient to stimulate T cells undergoing homeo-
static proliferation. Support for this idea is provided by the
finding that basal levels of IL-7 are elevated in T cell–
depleted conditions in humans, i.e., after BM transplanta-
tion, chemotherapy, and at late stages of HIV infection (46–
48). Thus far, however, our attempts to adapt the highly
sensitive immunoassay used to detect IL-7 in humans has
been unsuccessful for measuring mouse IL-7 levels.
The observation that homeostatic proliferation of
CD44hi CD8  cells involves both IL-7 and IL-15 provides
an explanation for the inhibition of proliferation induced
by coinjection of normal T cells. Here, the surprising find-
ing was the capacity of bulk populations of T cells to block
homeostatic proliferation of CD44hi CD8  cells applied
only to CD44hi CD8  inhibitors and not to CD44lo inhib-
itors. For inhibition mediated by CD44hi CD8  cells, our
suggestion is that, via IL-7R and CD122, these cells
caused depletion of both IL-7 and IL-15 and thus pre-
vented the proliferating T cells from contacting these cy-
tokines. Whereas CD44hi CD8  cells are IL-7Rhi
CD122hi, CD44lo cells are IL-7Rhi CD122lo. Hence, via
removal of IL-7, we expected that coinjection of CD44lo
cells would block homeostatic proliferation of CD44hi
CD8  cells, though only in IL-15  hosts. Yet, no inhibi-
tion was observed, even though CD44lo cells were injected
in large numbers (3–4   107). One explanation for this
finding is that, cell-for-cell, CD44lo cells are less efficient
than CD44hi cells at absorbing IL-7. Although this possi-
bility has not been excluded, we favor the notion that
CD44lo cells fail to reach the sites of CD44hi CD8  cell
proliferation. Thus, it would seem likely that, unlike naive
T cells, proliferation of CD44hi CD8  cells occurs not
only in the T cell–dependent areas but also in other sites,
e.g., the splenic white pulp, as well as in nonlymphoid tis-
sues. Hence, we envisage that the inhibitory T cells need
to reach these multiple sites in order to cause effective de-
pletion of both IL-7 and IL-15; only CD44hi and not
CD44lo inhibitors reach these sites.
The capacity of two different cytokines, IL-7 and IL-15,
to promote homeostatic proliferation of CD44hi CD8 
cells raises the question whether other  c cytokines con-
tribute to this process. This possibility would seem unlikely
because proliferation was almost undetectable in combined
IL-7  IL-15  hosts. However, the basal levels of other  c
cytokines in these mice may be too low to compensate for
the lack of IL-7 and IL-15. Therefore, a key issue is
whether the failure of CD44hi CD8  cells to undergo ho-
meostatic proliferation in IL-7  IL-15  hosts can be over-
come by injecting other  c cytokines, e.g., IL-4 or IL-9.
We are in the process of testing this possibility.
If we did find that homeostatic proliferation of CD44hi
CD8  cells can be driven by a spectrum of  c cytokines,
these cytokines might also have the potential to control the
normal homeostasis of CD44hi CD8  cells in T cell–suffi-
cient mice. As discussed earlier, normal homeostasis of
CD44hi CD8  cells seems to be under the sole control of a
single cytokine, IL-15, though joint exposure to another  c
cytokine, IL-2, is known to be inhibitory (28). However,
the decisive influence of IL-15 on CD44hi CD8  cells in
normal mice could simply indicate that levels of other  c
cytokines in vivo are too low to contribute to homeostasis.
If so, the question arises whether the strong dependence of
CD44hi CD8  cells on IL-15 can be overcome by raising in
vivo levels of other  c cytokines. In support of this idea we
have found that levels of CD44hi CD8  cells, including
CD122hi cells, increase substantially in IL-7 transgenic mice
and are also prominent in IL-15  IL-7 transgenic mice (44).
Therefore, the implication is that CD44hi CD8  cells are
only dependent on IL-15 when the concentration of IL-7 is
low; if levels of IL-7 are raised to above physiological levels,
IL-15 is no longer required. Whether raising levels of other
 c cytokines can substitute for IL-15 has not been studied.
In marked contrast to CD8  cells, we found no evidence
that  c cytokines are required for homeostatic proliferation
of memory phenotype CD4  cells. This finding is in agree-
ment with the report that memory CD4  cells can be gen-
erated from  c
  precursors (30, 31). Since homeostatic pro-
liferation of CD44hi CD4  cells was unimpeded in MHC
class I II  hosts, proliferation is apparently both MHC in-
dependent and  c cytokine independent. Whether prolifer-
ation of CD44hi CD4  cells is controlled by non- c cyto-
kines and/or by chemokines is unclear, although it is notable
that proliferation was not blocked by coinjecting either
CD44lo T cells or CD44hi CD8  cells. Whether bulk pop-
ulations of CD44hi CD4  cells (which are difficult to pre-
pare in large numbers) can block proliferation of CD44hi
CD4  cells has not been studied.
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